On July 8, 2021 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported its Co-founder and Chief Scientific Officer, Christopher Kirk, will participate in the "Novel Targets for Autoimmune Diseases" panel discussion at William Blair’s Biotech Focus Conference on Thursday, July 15, 2021, at 11:00 a.m. ET (Press release, Kezar Life Sciences, JUL 8, 2021, View Source [SID1234584716]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the panel may be accessed at the "Events & Presentations" section of Kezar’s website at View Source Kezar Life Sciences will maintain an archived replay of the webcast on its website for 90 days after the conference.